The selected biomarker panel using Wald’s backward selection method, for differential diagnosis of bvFTD from AD, consisted of NfL, SNAP25, Ng, and GluR4 (AUC = 0.86, CI: 0.79–0.92, p < 0.001). This evidence concerns the gene NEFL and Alzheimer disease.